This update features policy developments, media reports, and events supporting continued momentum for multiple V-BID Center initiatives.

Click here to view recent policy developments.

Click here to view recent center events.

Click here to view V-BID in recent news.

Click here to view V-BID in recent literature.

President’s Executive Order Promotes V-BID

President Trump recently issued an Executive Order on “Protecting and Improving Medicare for Our Nation’s Seniors,” which includes multiple provisions that promote V-BID concepts and directly impact the MA V-BID Model.

Updated U.S. Preventive Services Task Force Recommendation on BRCA-Related Cancer

The USPSTF now classifies risk assessment, genetic counseling, and genetic testing for women with risk factors associated with BRCA1/2 gene mutation as a “B”-rated service. For women without risk of this gene mutation, these services received a “D”-rating. Read more about clinical nuance here.

USPSTF Still Pans Screening for Pancreatic Cancer​

The USPSTF announced that screening for pancreatic cancer in low-risk adults with no signs or symptoms remains a “D”-rated service, reaffirming their 2004 statement. Visit our low-value care initiative to learn more on this topic.

CMS To Streamline MA V-BID Model Test Application Process

CMS is planning to align the application process for the Value-Based Insurance Design (V-BID) demonstration with Medicare Advantage bid submissions in 2021, and incorporate other changes to reduce plans’ burdens. Read more about V-BID in MA on our website.

Medicare Advantage Learning Collaborative Fly-In with Health Plan Alliance

In collaboration with Health Plan Alliance, this workshop was designed to arm Medicare Advantage and Special Needs Plans with the insights needed to better evaluate the unique opportunities that the MA V-BID Model presents for their health plans.

Webinar: "V-BID X: A New Plan Option for the Individual Health Insurance Market"

In July, the V-BID Center co-hosted a webinar with the Harvard Healthcare Markets & Regulation Lab introducing V-BID X, a novel benefit design that reduces consumer cost-sharing for targeted high-value services and increases cost-sharing for specific low-value services.

UPMC Diabetes Wellness Program to Cut Drug Spending, Chronic Care

UPMC launched a diabetes wellness program targeting Medicare Advantage members with, or at-risk for, diabetes. The program includes reduced copays for medications and evidence-based chronic disease management. Learn more about V-BID in MA here.

Wasteful Spending in U.S. Health Care Estimated at $760 - $935 Billion

New research reveals that about 25% of health care spending is on waste, with low-value care estimated at $75.7 to $101.2 billion. Read more about reducing low-value care.

Survey Projects Health Care Costs to Rise in 2020

A Willis Towers Watson survey reports that employers are increasingly turning to value-based insurance designs to manage costs and improve health outcomes.

Health Insurance Costs Hit a Record - Surpass $20,000 Per Year For a Typical Family

Annual health care for families now costs as much as buying a new car, pushing many Americans into plans with less generous coverage. In this article, Dr. Fendrick weighs in on the crisis.

Blue Cross Minnesota Announces $0 Insulin Copay

To increase access to care for beneficiaries with diabetes, Blue Cross Minnesota announced that they will will cover both Tier 1 and Tier 2 insulin medications at no cost to patients. Learn more about V-BID approaches to drug costs.

Michael Thompson: Getting to a Value-Based Benefit Design

In an AJMC interview, Michael Thompson, president and CEO of the National Alliance of Healthcare Purchaser Coalitions, advocates for clinically-nuanced cost-sharing.


NPR Marketplace: Inequality at a 50 Year High

On this episode of NPR’s Marketplace Podcast, Dr. Mark Fendrick weighs in on the consequences of high health care costs for Americans. Listen to Dr. Fendrick’s comments.

Catalyst for Payment Reform: Mark Fendrick Presents V-BID X

In a recent CPR Listening In (With Permission) podcast, Dr. Fendrick discusses a new cost-neutral health plan, V-BID X.

The Healthcare Policy Podcast: Dr. Mark Fendrick Discusses V-BID

Listen to Mark Fendrick, MD, explain the origins of Value-Based Insurance Design, as well as some of the V-BID center’s recent policy accomplishments.

JAMA: CLEAN Trial Examines Adherence Effect of No Charge Meds

This JAMA study reported that providing essential medications at no cost increases adherence and improves health outcomes. Read more about V-BID and drug costs.

Modern Healthcare: COPD Patients with High Insurance Deductibles More Likely to Skip Care​

Patients with COPD in high-deductible health plans reported skipping care more frequently than those without high deductibles. HDHPs with smarter deductibles can better serve the medical and financial needs of individuals with chronic conditions.

CMAJ: Should V-BID be Included in Canada’s National Pharmacy Program?

A recent CMAJ article discusses the implications of applying a value-based insurance design in Canada’s universal, single-payer, public pharmacy program.

Please Help Support the V-BID Center

As a non-profit entity, the V-BID Center relies on fundraising to support our research, education, and policy efforts.  Please help us continue our work by donating here. We truly appreciate your consideration.